دورية أكاديمية

Brody Disease, an Early-Onset Myopathy With Delayed Relaxation and Abnormal Gait: A Case Series of 9 Children

التفاصيل البيبلوغرافية
العنوان: Brody Disease, an Early-Onset Myopathy With Delayed Relaxation and Abnormal Gait: A Case Series of 9 Children
المؤلفون: Verhoeven, J.I., Kramer, Jasper, Seeger, J., Molenaar, J.P., Braakman, H.M.H., Kamsteeg, E.J., Rodenburg, R.J.T., Kusters, B., Koudijs, S., Engelen, B.G.M. van, Erasmus, C.E., Voermans, N.C.
المصدر: Neurology, 102, 5, pp. e209164
سنة النشر: 2024
المجموعة: Radboud University: DSpace
مصطلحات موضوعية: Radboudumc 0: Other Research DCMN: Donders Center for Medical Neuroscience, Radboudumc 12: Sensory disorders DCMN: Donders Center for Medical Neuroscience, Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience, Radboudumc 6: Metabolic Disorders Human Genetics, Radboudumc 6: Metabolic Disorders Paediatrics
الوصف: Item does not contain fulltext ; Brody disease is a rare autosomal recessive myopathy, caused by pathogenic variants in the ATP2A1 gene. It is characterized by an exercise-induced delay in muscle relaxation, often reported as muscle stiffness. Children may manifest with an abnormal gait and difficulty running. Delayed relaxation is commonly undetected, resulting in a long diagnostic delay. Almost all published cases so far were adults with childhood onset and adult diagnosis. With diagnostic next-generation sequencing, an increasing number of patients are diagnosed in childhood. We describe the clinical and genetic features of 9 children from 6 families with Brody disease. All presented with exercise-induced delayed relaxation, reported as difficulty running and performing sports. Muscle strength and mass was normal, and several children even had an athletic appearance. However, the walking and running patterns were abnormal. The diagnostic delay ranged between 2 and 7 years. Uniformly, a wide range of other disorders were considered before genetic testing was performed, revealing pathogenic genetic variants in ATP2A1. To conclude, this case series is expected to improve clinical recognition and timely diagnosis of Brody disease in children. We propose that ATP2A1 should be added to gene panels for congenital myopathies, developmental and movement disorders, and muscle channelopathies.
نوع الوثيقة: article in journal/newspaper
اللغة: unknown
العلاقة: https://repository.ubn.ru.nl/handle/2066/304798Test
DOI: 10.1212/WNL.0000000000209164
الإتاحة: https://doi.org/10.1212/WNL.0000000000209164Test
https://repository.ubn.ru.nl/handle/2066/304798Test
رقم الانضمام: edsbas.36AB62CE
قاعدة البيانات: BASE